Company closes strategic purchase of ultra-efficient analytical equipment, supporting sustainability initiatives
MELBOURNE, Fla., Dec. 07, 2023 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a leader in the biotech industry, today proudly announced the retirement of an additional 400,000,000 shares of its common stock, bringing the total number of shares retired to 2 billion. This significant move is part of the company's ongoing commitment to enhance shareholder value. Furthermore, the company highlights recent acquisitions, boosting the company’s assets portfolio to well over $1 million this month.
David Oswald, CEO of Branded Legacy, Inc., commented on the retirement, "In efforts to under promise and over deliver, we expect to retire additional shares in the coming months. We consider economic sustainability as a core aspect of our overall mission. The reduction of 2 billion shares is a testament to the integrity with which we conduct our fiduciary responsibilities. These actions underscore our ongoing commitment to maintaining a healthy share structure."
This share retirement is part of Branded Legacy, Inc.'s broader strategy to streamline its share structure and improve its market standing. By reducing the number of shares available in the market, the company aims to increase the value of the remaining shares, thereby benefiting its loyal shareholders.
The company would also like to announce that today it purchased ultra-efficient analytical and chemical recycling equipment that has empowered the company to reach new levels of efficiency and quality. These systems enable machinery to operate in tandem, recycling the chemical inputs used in analytical and purification processes. This brings the capability of in-house validation and significantly reduces company overhead.
In addition to the share retirement, Branded Legacy, Inc.'s team is working to finalize the details of a $6 million acquisition agreement, a strategic move that will further enhance the company's market position and product offerings.
In the company’s recent major news, it announced the successful acquisition of MariJ Pharmaceuticals, Inc. This acquisition, valued at well over $1,000,000, included USDA organic certifications, state-of-the-art equipment, a multi-vehicle fleet, multi-state licensing, award-winning products, and a patent among a multitude of inventory and assets. This has significantly expanded the company’s portfolio and capabilities, demonstrating commitment to growth and innovation in the biotech sector, all acquired at pennies on the dollar.
About Branded Legacy, Inc.: Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services. The company's diverse portfolio includes ventures in biotechnology, digital solutions, and wellness products, all aimed at enhancing the quality of life for its customers. Branded Legacy's strategic approach to growth involves identifying and integrating promising businesses and technologies that align with its mission to deliver sustainable, high-quality products and services.
About MariJ Pharmaceuticals, Inc.: MariJ Pharmaceuticals, Inc., based in Clearwater, Florida, specializes in the certified organic mobile extraction and production of CBD from industrial hemp. They offer a range of cannabinoid products and services tailored for the pharmaceutical and bio-product industries, ensuring compliance with legal THC limits. Their expertise extends to mobile CO2 certified organic, patented extraction services and the legal distribution of both wholesale and retail products in all U.S. markets. MariJ is also known for its commitment to HIPAA compliance and good corporate governance. More information can be found at the MariJ Website.
Safe Harbor Statement on Forward-Looking Language: This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.
